Home > Insider Trading > Filing (0000903423-15-000336)

Filing Details

Accession Number:: 0000903423-15-000336
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-05-18 21:59:21
Reporting Period:: 2015-05-14

Filing Date:: 2015-05-18
Accepted Time:: 2015-05-18 20:59:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1488613	Foundation Medicine Inc.	FMI	Services-Medical Laboratories (8071)	271316416

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1288776	Google Inc.	1600 Amphitheatre Parkway Mountain View CA 94043	No	No	Yes	No
1586699	Google Ventures 2011, L.p.	1600 Amphitheatre Parkway Mountain View CA 94043	No	No	Yes	No
1639805	Google Ventures 2011 Gp, L.l.c.	1600 Amphitheatre Parkway Mountain View CA 94043	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-05-14	8,600	$38.57	183,860	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.50 to $38.78, inclusive. The Reporting Persons undertake to provide to Foundation Medicine, Inc., any security holder of Foundation Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.
Shares directly held by Google Ventures 2011, L.P. Google Ventures 2011 GP, L.L.C., the general partner of Google Ventures 2011, L.P., and Google Inc., the managing member of Google Ventures 2011 GP, L.L.C., may each be deemed to have sole power to vote and dispose of these shares. Each of Google Ventures 2011 GP, L.L.C. and Google Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.
Solely as a result of the Investor Rights Agreement filed as Exhibit 4.1 of the Form 8-K filed by Issuer with the Securities and Exchange Commission on January 12, 2015, the Reporting Persons may be deemed to have beneficial ownership of the (a) 20,604,288 shares directly held by Roche Holdings, Inc., an indirect wholly owned subsidiary of Roche Holding Ltd ("Roche" and together with Roche Holdings, Inc. and Roche Finance Ltd, the "Roche Entities"), (b) 414,823 shares directly held by Roche Finance Ltd, a wholly owned subsidiary of Roche and (c) shares previously held by Third Rock Ventures, L.P. ("TRV"). The Reporting Person disclaims beneficial ownership of any shares of Issuer held by any of the Roche Entities and TRV.